A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the change in 24-hour ambulatory blood pressure
monitoring (ABPM) between baseline (Day 0) and Day 120 following 4 months of testosterone
therapy with Natesto.